Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P W Armstrong

Showing results (201-210 of 281) with videos related to

Pageof 29
Sort By:
The Canadian Journal of Cardiology|November 1, 1994
Graded exercise testing following thrombolytic therapy for acute myocardial infarction: the importance of timing and infarct location. TPAT Study GroupC D Morgan, M Gent, P A Daly, et al.
American Heart Journal|June 18, 1998
Beyond drug therapy: nonpharmacologic care of the patient with advanced heart failureB F Uretsky, I Pina, R J Quigg, et al.
Journal of the American College of Cardiology|June 1, 1991
Coronary patency, infarct size and left ventricular function after thrombolytic therapy for acute myocardial infarction: results from the tissue plasminogen activator: Toronto (TPAT) placebo-controlled trial. TPAT Study GroupC D Morgan, R S Roberts, A Haq, et al.
Archives of Internal Medicine|February 15, 2001
Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and SurvivalB M Massie, P W Armstrong, J G Cleland, et al.
Circulation|May 1, 1991
Response of atrial natriuretic factor to acute and chronic increases of atrial pressures in experimental heart failure in dogs. Role of changes in heart rate, atrial dimension, and cardiac tissue concentrationG W Moe, E A Grima, C Angus, et al.
Journal of the American College of Cardiology|June 1, 1995
Noninvasive assessment of speed and stability of infarct-related artery reperfusion: results of the GUSTO ST segment monitoring study. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesA Langer, M W Krucoff, P Klootwijk, et al.
European Heart Journal|November 10, 2000
Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trialL Rydén, P W Armstrong, J G Cleland, et al.
European Heart Journal|May 1, 1996
Non-invasive prediction of reperfusion and coronary artery patency by continuous ST segment monitoring in the GUSTO-I trialP Klootwijk, A Langer, S Meij, et al.
The American Journal of Cardiology|May 1, 1997
Incidence and impact on outcome of streptokinase allergy in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA in Occluded Coronary ArteriesT S Tsang, R M Califf, A L Stebbins, et al.
Circulation|October 1, 1990
Fibrillar collagen and remodeling of dilated canine left ventricleK T Weber, R Pick, M A Silver, et al.
Pageof 29

Showing results (201-210 of 281) with videos related to

Sort By:
Pageof 29
The Canadian Journal of Cardiology|November 1, 1994
Graded exercise testing following thrombolytic therapy for acute myocardial infarction: the importance of timing and infarct location. TPAT Study GroupC D Morgan, M Gent, P A Daly, et al.
American Heart Journal|June 18, 1998
Beyond drug therapy: nonpharmacologic care of the patient with advanced heart failureB F Uretsky, I Pina, R J Quigg, et al.
Journal of the American College of Cardiology|June 1, 1991
Coronary patency, infarct size and left ventricular function after thrombolytic therapy for acute myocardial infarction: results from the tissue plasminogen activator: Toronto (TPAT) placebo-controlled trial. TPAT Study GroupC D Morgan, R S Roberts, A Haq, et al.
Archives of Internal Medicine|February 15, 2001
Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and SurvivalB M Massie, P W Armstrong, J G Cleland, et al.
Circulation|May 1, 1991
Response of atrial natriuretic factor to acute and chronic increases of atrial pressures in experimental heart failure in dogs. Role of changes in heart rate, atrial dimension, and cardiac tissue concentrationG W Moe, E A Grima, C Angus, et al.
Journal of the American College of Cardiology|June 1, 1995
Noninvasive assessment of speed and stability of infarct-related artery reperfusion: results of the GUSTO ST segment monitoring study. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesA Langer, M W Krucoff, P Klootwijk, et al.
European Heart Journal|November 10, 2000
Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trialL Rydén, P W Armstrong, J G Cleland, et al.
European Heart Journal|May 1, 1996
Non-invasive prediction of reperfusion and coronary artery patency by continuous ST segment monitoring in the GUSTO-I trialP Klootwijk, A Langer, S Meij, et al.
The American Journal of Cardiology|May 1, 1997
Incidence and impact on outcome of streptokinase allergy in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA in Occluded Coronary ArteriesT S Tsang, R M Califf, A L Stebbins, et al.
Circulation|October 1, 1990
Fibrillar collagen and remodeling of dilated canine left ventricleK T Weber, R Pick, M A Silver, et al.
Pageof 29